1. Document de presse | 2024.04.26

   Bronchiolitis: two French studies demonstrate the effectiveness of Beyfortus® in preventing serious illness and reducing hospital admissions among infants

   After a 2022/2023 season marked by a severe epidemic of bronchiolitis due to respiratory syncytial virus (RSV), in particular in terms of emergency department visits and hospital admissions, on September 15, 2023 the French Government launched a preventive immunization campaign, administering nirsevimab (Beyfortus®), to protect infants and reduce the circulation of the virus.To assess the...

2. News | 2022.03.22

   World Water Day: several water-related diseases still exist

   World Water Day is held on March 22, 2022. The theme for this year’s edition is: "Groundwater – making the invisible visible". On this occasion, learn more about diseases related to water access – predominantly infectious diseases – in our fact sheets and some of the initiatives implemented by the Institut Pasteur in Paris and the Pasteur Network.

3. News | 2022.03.22

   Ukrainian scientists: offer to join a host laboratory at the Institut Pasteur in Paris

   In view of the ongoing war in Ukraine, the Institut Pasteur is providing funding to host Ukrainian scientists in its research laboratories.

4. News | 2021.11.08

   The Institut Pasteur adopts a Charter for Open Access to Scientific Publications

   In 2021, the Institut Pasteur produced a Charter for Open Access to Publications. This charter is part of a broader commitment to open science, as reaffirmed in the 2019-2023 Strategic Plan.

5. News | 2021.10.25

   The Institut Pasteur adopts a new data management and sharing policy

   The Institut Pasteur recently introduced a new policy for managing and sharing research data and software codes. The policy is part of a wider commitment to open science that began in 2004, the same year as the Berlin Declaration on Open Access to Knowledge, and was reaffirmed in the 2019-2023 Strategic Plan.

6. News | 2023.02.22

   Collaboration with UCSF QBI: Institut Pasteur establishes presence in USA

   A delegation from the Institut Pasteur will visit San Francisco during the week of February 28 to March 2, 2023, to present a series of events and workshops that will provide an overview of the Institut Pasteur-UCSF QBI partnership (Institut Pasteur-University of California, San Francisco, Quantitative Biosciences Institute). These events will also promote the establishment of a Center of...

7. News | 2023.06.02

   Creation of the Pasteur International Unit Fungal Extracellular Vesicles

   The Institut Pasteur announces the creation of the Pasteur International Unit Fungal Extracellular Vesicles, in collaboration with the FioCruz - Oswaldo Cruz Foundation (Brazil) and the University of Birmingham (UK). The Pasteur International Joint Research Units are jointly created with two or more research teams, working together within the Pasteur Network.

8. News | 2023.07.26

   NK cells effective against pneumococcus

   Natural killer (NK) cells are mainly studied for their ability to eliminate tumor cells or cells infected with viruses. Scientists have now demonstrated that these cells also have particular properties that enable them to defend the body from a deadly bacterium, making them a potential alternative to antibiotics.

9. News | 2023.09.04

   Using intravital imaging to uncover the secrets of neural stem cells

   The brain contains stem cells that are kept in a dormant state. Under certain conditions, these cells can activate, divide and self-renew or produce new functional neurons. Using an imaging technique, scientists at the Institut Pasteur have identified cellular parameters that can predict fate determination.

10. News | 2023.12.10

    Diphtheria: A hundred years ago, the first toxoid vaccine

    In 1923, veterinarian Gaston Ramon discovered the diphtheria toxoid, a molecule capable of neutralizing the toxin produced by diphtheria bacteria. Within a year he had conceptualized the notion of adjuvants and developed the forerunner of today's DTP vaccine. His discoveries would go on to save thousands of lives.

Pages